Literature DB >> 6752294

Serum macrophage migration inhibition activity in patients with leprosy.

T H Rea, T Yoshida.   

Abstract

We have found that 26 of 54 (48%) untreated patients with leprosy had serum migration inhibitory activity, and that this was present in tuberculoid, borderline, and lepromatous forms of the disease. Patients with active recreational states; i.e., reversal reactions, Lucio's reaction, or erythema nodosum leprosum, were particularly apt to have this inhibitory activity. The prevalence of inhibitory activity did not vary significantly with treatment, dinitrochlorobenzene responsiveness, tuberculin responsiveness, or serum lysozyme levels.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6752294     DOI: 10.1111/1523-1747.ep12500088

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  4 in total

1.  Epidermal keratinocyte Ia expression, Langerhans cell hyperplasia and lymphocytic infiltration in skin lesions of leprosy.

Authors:  T H Rea; J Y Shen; R L Modlin
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

2.  In situ characterization of T lymphocyte subsets in the reactional states of leprosy.

Authors:  R L Modlin; J F Gebhard; C R Taylor; T H Rea
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

3.  Circulating monocyte migration inhibitory factor in serum of Graves' ophthalmopathy patients: a parameter for disease activity?

Authors:  R van der Gaag; L Broersma; M P Mourits; L Koornneef; W M Wiersinga; M P Prummel; A Berghout
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

Review 4.  A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum.

Authors:  Anastasia Polycarpou; Stephen L Walker; Diana N J Lockwood
Journal:  Front Immunol       Date:  2017-03-13       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.